Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,187 | -18,117 | -10,284 | -1,378 | -28,371 |
| Depreciation Amortization | 7,734 | 5,721 | 3,690 | 1,827 | 8,155 |
| Income taxes - deferred | N/A | N/A | -1,372 | N/A | N/A |
| Accounts receivable | -3,675 | -1,346 | -2,632 | 699 | -5 |
| Other Working Capital | -4,690 | -3,675 | -3,417 | -2,802 | -11,047 |
| Other Operating Activity | 73,028 | -7,119 | -4,751 | -8,958 | -6,348 |
| Operating Cash Flow | $-29,789 | $-24,537 | $-18,765 | $-10,612 | $-37,616 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -811 | -722 | -427 | -255 | -668 |
| Investing Cash Flow | $-811 | $-722 | $-427 | $-255 | $-668 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | N/A | -18,875 | 28,037 |
| Debt Repayment | -19,048 | -19,009 | -18,931 | N/A | -15,312 |
| Common Stock Issued | 37,978 | 38,145 | 27,574 | 18,914 | 36,206 |
| Other Financing Activity | -82 | -81 | 0 | -58 | -1,707 |
| Financing Cash Flow | $18,848 | $19,054 | $8,643 | $-19 | $47,224 |
| Exchange Rate Effect | 224 | 273 | 124 | 37 | 246 |
| Beginning Cash Position | 16,160 | 16,160 | 16,160 | 16,160 | 6,974 |
| End Cash Position | 4,632 | 10,229 | 5,735 | 5,311 | 16,160 |
| Net Cash Flow | $-11,528 | $-5,932 | $-10,425 | $-10,850 | $9,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,789 | -24,537 | -18,765 | -10,612 | -37,616 |
| Capital Expenditure | -811 | -722 | -427 | -255 | -668 |
| Free Cash Flow | -30,600 | -25,258 | -19,192 | -10,867 | -38,284 |